Agenda - Friday April 13th, 2018

Time: TBA The Price is Right? U.S. Pharmaceutical Pricing Transparency and Sustainability

High and increasing price tags on brand medications in the U.S. pharmaceutical market have made headlines and drawn public ire in recent years. This session will focus on how pharmaceutical products are priced, the policies surrounding these decisions, and what the future of product pricing holds given industry trends: increase in large molecule drugs, the orphan drug market and biotechnology solutions. The session will bring in perspectives from the private sector to represent the life sciences industry, and public-sector voices to discuss how the U.S.’s policy landscape led to modern prices and how we envision future pricing decisions.

Time: TBA The Changing Landscape of Venture Capital in Healthcare: Innovation and Financing Next Gen Solutions

Over the past decade, healthcare entrepreneurship has boomed with innovators developing solutions in health technology and delivery that aim to fix the challenges and complexities of the U.S. healthcare system. As the quantity and size of healthcare start-ups on the market continue to rise, investors have financed these solutions through venture capital. This session will explore the changing and growing role of venture capital in healthcare and how investors have helped to bring next generation, high-impact solutions for access to the market. While biotechnology firms have commanded the most VC investments in healthcare in past years, delivery-oriented enterprises focused on access are attracting more funds in recent years - a trend the session will emphasize and have experts speak on. The session will ideally include voices from digital health start-ups in various stages, and from current and former healthcare VC investors.

Time: TBA Frontiers of Healthcare Technology: The Role of Telemedicine and Application-Based Care

As the healthcare industry continues to innovative to expand and improve care, technological solutions have become increasingly important. This session will specifically focus on telemedicine and the advances that this technology has made, as well as the rise of patient-centered applications, like those focused on personalized medicine and lifestyle management. The session will ideally include speakers from organizations who have designed and implemented tele-doc programs, like payers, and other applications aimed to improve access.

Time: TBA When Access Should be Limited: Combating Waste and Overutilization in US Healthcare

With the Choosing Wisely initiative and others like it, there is a newfound focus on preventing wasteful or unnecessary treatment in healthcare. This session will explore various ways in which delivery providers and insurers are countering overutilization and promoting high value care. How should we educate patients and providers on this topic and change prevailing views that “more is always better”? Which solutions are most successful for limiting unnecessary services? 

Time: TBA Healthcare Policy and the Employee: The Future of Employer-Sponsored Healthcare Coverage

Employer-sponsored health insurance has remained an integral component of the U.S. healthcare system for more than fifty years. As political tensions continue over the appropriate means for providing healthcare coverage in the U.S., understanding the unique and important role of employers is critical. This session will focus on employer-sponsored healthcare coverage, discussing its history, recent changes, and necessary policy solutions for the future. It will be relevant for employers, employees, and those innovating coverage outside of employer-sponsored care.

Time: TBA The Role of Partnerships in Improving Population Health: Who Should Partner, for What and How? 

With the shift towards population health well underway, there is increasing focus on integrating services beyond the four walls of the hospital to improve the health of communities overall. This movement has not only included new roles for non-profit organizations (e.g., legal aid), but also for a wide range of private partners. This session will explore a range of innovative partnerships aimed at achieving the Triple Aim. How are these partnerships structured and financed? What leads to their success; and, equally important, what hinders them?

Time: TBA Beyond the Hospital:  The Role of Retail Clinics and Urgent Care as Alternative Sites of Care

Former Vice President Hubert Humphrey once said, “The moral test of government is how that government treats those who are in the dawn of life, the children; those who are in the twilight of life, the elderly; and those who are in the shadows of life, the sick, the needy, and the handicapped." As healthcare consumes a larger portion of annual GDP and life expectancy increases produce an older population former Vice President Humphrey’s words carry heavier meaning. In this panel, we discuss the unique, chronic health care needs of older populations and the potential for long term care and home health access to manage chronic health conditions and physical mobility limitations without exacerbating health expenditures.

Time: TBA Aging Populations in Healthcare:  The Impact of Long Term Care and Home Health Access on Health Expenditures and Patient Outcomes

Former Vice President Hubert Humphrey once said, “The moral test of government is how that government treats those who are in the dawn of life, the children; those who are in the twilight of life, the elderly; and those who are in the shadows of life, the sick, the needy, and the handicapped." As healthcare consumes a larger portion of annual GDP and life expectancy increases produce an older population former Vice President Humphrey’s words carry heavier meaning. In this panel, we discuss the unique, chronic health care needs of older populations and the potential for long term care and home health access to manage chronic health conditions and physical mobility limitations without exacerbating health expenditures.

Time: TBA Battling Inequity:  The Role of Community Stakeholders in Addressing Social Determinants of Health Across the Care Continuum

Despite continuous breakthroughs in medical research and advances in developing novel pharmaceutical agents, there continues to be rampant health inequity. Chronic and acute conditions alike continuously plague communities along sociodemographic axes including race, gender, and socioeconomic status. As health care shifts toward a preventative care lens the question on everyone’s minds remains – who is getting sicker and why? In this panel, we discuss the role of community stakeholders in ameliorating health inequity before, during, and after acute medical care.

Time: TBA The Case for Integration: How Can Successful Models Be Replicated and Scaled?

Example Panelists: Kaiser, Intermountain, Geisinger, Bright, CVS/Aetna Some integrated health systems have demonstrated the ability to provide high quality services while controlling costs. Novel partnerships between health plans and health systems are also sprouting up. Is vertical integration an alternative to horizontal consolidation that can keep costs down and quality up? Why do we see integration in some regions, and not in others? How can successful models be replicated and scaled?